Phase II trial of capecitabine plus cisplatin as first‐line therapy in patients with metastatic nasopharyngeal cancer
暂无分享,去创建一个
Muh-Hwa Yang | R. Hong | K. Seetalarom | W. Ng | D. Chua | W. Sze | J. Kurnianda | Cheng-Hsu Wang | K. Shotelersuk | H. Yiu | A. Ng | A. W. Ng | G. Krishnan